ACRS Q2 2025 Earnings — Aclaris Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ACRSAclaris Therapeutics, Inc.

$435M

Q2 2025 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$2M-35.8% YoY

Gross Profit

-$73,000-4.1% margin

Operating Income

-$18M-1035.9% margin

Net Income

-$15M-868.3% margin

EPS (Diluted)

$-0.13

QoQ Revenue Growth

+22.1%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$10M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$189M

Total Liabilities

$57M

Stockholders' Equity

$132M

Cash & Equivalents

$25M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$3M	-35.8%
Gross Profit	-$73,000	$857,000	-108.5%
Operating Income	-$18M	-$13M	-43.2%
Net Income	-$15M	-$11M	-40.4%

Revenue Segments

License and Service

$1M75%

Contract research

$442,00025%